Clinical Trial Update: Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining adipocyte-directed therapy with pioglitazone or tirzepatide for normal-weight diabetes; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Stanford University | Conditions: Diabetes Mellitus, Type 2, Diabetes | Phase 4 | Status: RECRUITING